Exploring the General Practitioners' Perception of the Inter-professional Care of Rheumatoid Arthritis Patients (GEPRA-II): a Qualitative Interview Study

Overview

Journal BMC Prim Care

Date 2025 Jan 23

PMID 39844035

Authors

Anne-Laure Yailian

Audrey Janoly-Dumenil

Emmanuelle Vignot

Aurelie Fontana

Charline Estublier

Cyrille Confavreux

Roland Chapurlat

Claude Dussart

Humbert de Freminville

Affiliations

Soon will be listed here.

Abstract

Background: A lack of medication adherence among patients with rheumatoid arthritis (RA) has been reported. Inter-professional collaborations seem essential for an optimal therapeutic management of patients. The aim of this study was to analyse the barriers and facilitators of general practitioners (GPs) for the implementation of collaborative support programmes in RA.

Methods: A qualitative semi-structured study using face-to-face or telephone interviews was conducted. Eligible participants included French GPs referring patients with RA. Interviews were audio-recorded and then transcribed. Data were analysed using Braun and Clarke's thematic analysis framework with Nvivo12 software.

Results: Nineteen GPs were interviewed between August 2019 and February 2020. Five themes were identified in the care of their patients with RA. GPs reported being mainly involved in diagnosis and orientation, and frequently asked for pain management and explanation/reformulation of previously given information. They perceived their patients to be adherent to their treatments, although they frequently identified reasons for non-adherence. Regarding their perception of the community-hospital relationship, they sometimes considered it insufficient and expected more immediate interactions. Additionally, most interviewed GPs had no expectation regarding increased collaborations with community pharmacists (CPs) and several GPs were motivated to be more involved in a patient support programme. However, barriers were identified: lack of time and training, and insufficient payment.

Conclusions: The implementation of a collaborative patient support programme in RA should be developed taking into account the barriers and facilitators identified by GPs who appeared to be aware of the causes of potential non-adherence, and were particularly interested in receiving more information about the therapeutic monitoring of patients by hospital professionals.

References

Frantzen L, Cohen J, Trope S, Beck M, Munos A, Sittler M . Patients' information and perspectives on biosimilars in rheumatology: A French nation-wide survey. Joint Bone Spine. 2019; 86(4):491-496. DOI: 10.1016/j.jbspin.2019.01.001. View

Bak-Sosnowska M, Wyszomirska J, Daniel-Sielanczyk A . Selected psychological factors and medication adherence in patients with rheumatoid arthritis. Reumatologia. 2021; 59(2):90-97. PMC: 8103406. DOI: 10.5114/reum.2021.105433. View

Fautrel B, Balsa A, van Riel P, Casillas M, Capron J, Cueille C . Influence of route of administration/drug formulation and other factors on adherence to treatment in rheumatoid arthritis (pain related) and dyslipidemia (non-pain related). Curr Med Res Opin. 2017; 33(7):1231-1246. DOI: 10.1080/03007995.2017.1313209. View

Chowdhury T, Thapa A, Kadakia N, Khadka N, Gousy N . Propofol Infusion Syndrome: A Rare Complication From a Common Medication. Cureus. 2022; 14(11):e31940. PMC: 9794362. DOI: 10.7759/cureus.31940. View

Choquette D, Chan J, Bardi M, Whiskin C, Torani G, Smith B . Monitoring the transition of patients on biologics in rheumatoid arthritis: Consensus guidance for pharmacists. Pharm Pract (Granada). 2021; 19(3):2377. PMC: 8455126. DOI: 10.18549/PharmPract.2021.3.2377. View

Farias Teixeira M, Bonjorno L, Menezes P, Gigante S, Dib S, Oliveira F . Diagnostic Agreement Among General Practitioners, Residents, and Senior Rheumatologists for Rheumatic Diseases. J Clin Rheumatol. 2022; 28(6):293-299. DOI: 10.1097/RHU.0000000000001854. View

Walraven B, Ponjee G, Heideman W, Carkit F . Medication reviews in hospitalized patients: a qualitative study on perceptions of primary and secondary care providers on interprofessional collaboration. BMC Health Serv Res. 2020; 20(1):902. PMC: 7526422. DOI: 10.1186/s12913-020-05744-y. View

Hope H, Hyrich K, Anderson J, Bluett J, Sergeant J, Barton A . The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate. Rheumatology (Oxford). 2019; 59(1):213-223. DOI: 10.1093/rheumatology/kez274. View

Cohen J, Trope S, Paubel P, Munos A, Bocquet F . Preconceived notions about biosimilars-a French experience. Clin Rheumatol. 2020; 39(8):2251-2254. DOI: 10.1007/s10067-020-05229-7. View

Saunders B, Sim J, Kingstone T, Baker S, Waterfield J, Bartlam B . Saturation in qualitative research: exploring its conceptualization and operationalization. Qual Quant. 2018; 52(4):1893-1907. PMC: 5993836. DOI: 10.1007/s11135-017-0574-8. View

10.

Smolen J, Landewe R, Bijlsma J, Burmester G, Dougados M, Kerschbaumer A . EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update. Ann Rheum Dis. 2020; 79(6):685-699. DOI: 10.1136/annrheumdis-2019-216655. View

11.

Suris X, Cerda D, Ortiz-Santamaria V, Ponce A, Simon J, Calvo E . A rheumatology consultancy program with general practitioners in Catalonia, Spain. J Rheumatol. 2007; 34(6):1328-31. View

12.

Garneau K, Iversen M, Tsao H, Solomon D . Primary care physicians' perspectives towards managing rheumatoid arthritis: room for improvement. Arthritis Res Ther. 2011; 13(6):R189. PMC: 3334638. DOI: 10.1186/ar3517. View

13.

Blondal A, Jonsson J, Kalvemark Sporrong S, Almarsdottir A . General practitioners' perceptions of the current status and pharmacists' contribution to primary care in Iceland. Int J Clin Pharm. 2017; 39(4):945-952. DOI: 10.1007/s11096-017-0478-7. View

14.

Daei A, Soleymani M, Ashrafi-Rizi H, Zargham-Boroujeni A, Kelishadi R . Clinical information seeking behavior of physicians: A systematic review. Int J Med Inform. 2020; 139:104144. DOI: 10.1016/j.ijmedinf.2020.104144. View

15.

Joplin S, van der Zwan R, Joshua F, Wong P . Medication adherence in patients with rheumatoid arthritis: the effect of patient education, health literacy, and musculoskeletal ultrasound. Biomed Res Int. 2015; 2015:150658. PMC: 4427825. DOI: 10.1155/2015/150658. View

16.

van den Bemt B, Zwikker H, van den Ende C . Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature. Expert Rev Clin Immunol. 2012; 8(4):337-51. DOI: 10.1586/eci.12.23. View

17.

Geurts M, van der Flier M, de Vries-Bots A, Brink-van der Wal T, de Gier J . Medication reconciliation to solve discrepancies in discharge documents after discharge from the hospital. Int J Clin Pharm. 2013; 35(4):600-7. DOI: 10.1007/s11096-013-9776-x. View

18.

Meyfroidt S, Stevens J, De Lepeleire J, Westhovens R, De Cock D, Van der Elst K . A general practice perspective on early rheumatoid arthritis management: A qualitative study from Flanders. Eur J Gen Pract. 2015; 21(4):231-7. DOI: 10.3109/13814788.2015.1084279. View

19.

Daien C, Hua C, Gaujoux-Viala C, Cantagrel A, Dubremetz M, Dougados M . Update of French society for rheumatology recommendations for managing rheumatoid arthritis. Joint Bone Spine. 2018; 86(2):135-150. DOI: 10.1016/j.jbspin.2018.10.002. View